Peptide inhibition myointimal proliferation angiopeptin somatostatin analogue Vascular smooth muscle cell hyperplasia major component atherogenesis various animal models Angiopeptin cyclic octapeptide analogue somatostatin myointimal proliferation response endothelial cell injury rat carotid artery rabbit aorta iliac arteries coronary arteries transplanted rabbit hearts Angiopeptin serum lipid profiles nonhuman primates unlikely antiproliferative effect alterations cholesterol metabolism Angiopeptin peptide analogues somatostatin potent inhibitors growth hormone release insulin-like growth production inhibition smooth muscle cell proliferation vivo property common somatostatin analogues plasma growth hormone growth hormone-dependent insulin-like growth production physiologic stimuli myointimal proliferation vivo Angiopeptin incorporation rat carotid artery explants local effect autocrine paracrine mechanisms cell growth view potent inhibitory effect smooth muscle cell replication angiopeptin clinical utility restenosis percutaneous transluminal coronary angioplasty accelerated coronary atherosclerosis cardiac transplantation 